159 related articles for article (PubMed ID: 22130958)
1. Association of serum calcitonin with coronary artery disease in individuals with and without chronic kidney disease.
Kanbay M; Wolf M; Selcoki Y; Solak Y; Ikizek M; Uysal S; Segall L; Armutcu F; Eryonucu B; Duranay M; Goldsmith D; Covic A
Int Urol Nephrol; 2012 Aug; 44(4):1169-75. PubMed ID: 22130958
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor 23 and fetuin A are independent predictors for the coronary artery disease extent in mild chronic kidney disease.
Kanbay M; Nicoleta M; Selcoki Y; Ikizek M; Aydin M; Eryonucu B; Duranay M; Akcay A; Armutcu F; Covic A
Clin J Am Soc Nephrol; 2010 Oct; 5(10):1780-6. PubMed ID: 20576822
[TBL] [Abstract][Full Text] [Related]
3. Serum 25-hydroxyvitamin D as an independent determinant of 1-84 PTH and bone mineral density in non-diabetic predialysis CKD patients.
Tomida K; Hamano T; Mikami S; Fujii N; Okada N; Matsui I; Nagasawa Y; Moriyama T; Ito T; Imai E; Isaka Y; Rakugi H
Bone; 2009 Apr; 44(4):678-83. PubMed ID: 19111635
[TBL] [Abstract][Full Text] [Related]
4. Association among serum fetuin-A level, coronary artery calcification, and bone mineral densitometry in maintenance hemodialysis patients.
Kirkpantur A; Altun B; Hazirolan T; Akata D; Arici M; Kirazli S; Turgan C
Artif Organs; 2009 Oct; 33(10):844-54. PubMed ID: 19681840
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal Evolution of Markers of Mineral Metabolism in Patients With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
Isakova T; Cai X; Lee J; Mehta R; Zhang X; Yang W; Nessel L; Anderson AH; Lo J; Porter A; Nunes JW; Negrea L; Hamm L; Horwitz E; Chen J; Scialla JJ; de Boer IH; Leonard MB; Feldman HI; Wolf M;
Am J Kidney Dis; 2020 Feb; 75(2):235-244. PubMed ID: 31668375
[TBL] [Abstract][Full Text] [Related]
6. Mineral abnormalities and long-term graft function in pediatric renal transplant recipients: a role for FGF-23?
Wesseling-Perry K; Tsai EW; Ettenger RB; Jüppner H; Salusky IB
Nephrol Dial Transplant; 2011 Nov; 26(11):3779-84. PubMed ID: 21441401
[TBL] [Abstract][Full Text] [Related]
7. Correlation of FGF-23 With Biochemical Markers and Bone Density in Chronic Kidney Disease-Bone Mineral Density Disorder.
Hussain I; Tandi R; Singh G; Kaur G; Abhishek ; Dodda S; Patel D; Natarajan B; Maram T; Kedia A; Vempati R; Sahu S; Choubey U
Cureus; 2023 Jan; 15(1):e33879. PubMed ID: 36812096
[TBL] [Abstract][Full Text] [Related]
8. Relationship of fibroblast growth factor 23 and fetuin--A to coronary atherosclerosis.
Akin F; Celik O; Altun I; Ayca B; Diker VO; Satılmıs S; Sahin C
J Diabetes Complications; 2015; 29(4):550-5. PubMed ID: 25772252
[TBL] [Abstract][Full Text] [Related]
9. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
10. Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function.
Roos M; Lutz J; Salmhofer H; Luppa P; Knauss A; Braun S; Martinof S; Schömig A; Heemann U; Kastrati A; Hausleiter J
Clin Endocrinol (Oxf); 2008 Apr; 68(4):660-5. PubMed ID: 17970775
[TBL] [Abstract][Full Text] [Related]
11. Predictors of coronary calcification in Indian hemodialysis patients.
Jasani R; Hase N; Kumar R; Dedhia P; Jamale T; Bajpai D
Saudi J Kidney Dis Transpl; 2018; 29(4):822-827. PubMed ID: 30152418
[TBL] [Abstract][Full Text] [Related]
12. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease
.
Yin C; Cheng C; Wang J; Zhang L; Purrunsing Y; Yang G; Zeng M; Huang H; Ren W; Ye Y; Ma H; Xing C; Wang N
Clin Nephrol; 2020 Feb; 93(2):65-76. PubMed ID: 31793871
[TBL] [Abstract][Full Text] [Related]
13. Uric acid and pentraxin-3 levels are independently associated with coronary artery disease risk in patients with stage 2 and 3 kidney disease.
Kanbay M; Ikizek M; Solak Y; Selcoki Y; Uysal S; Armutcu F; Eryonucu B; Covic A; Johnson RJ
Am J Nephrol; 2011; 33(4):325-31. PubMed ID: 21389698
[TBL] [Abstract][Full Text] [Related]
14. Relation of fibroblast growth factor-23 and cardiovascular calcification in end-stage kidney disease patients on regular hemodialysis.
El Baz TZ; Khamis OA; Ahmed Gheith OA; Abd Ellateif SS; Abdallah AM; Abd El Aal HC
Saudi J Kidney Dis Transpl; 2017; 28(1):51-60. PubMed ID: 28098103
[TBL] [Abstract][Full Text] [Related]
15. Associations of fibroblast growth factor 23 and fetuin-A with coronary plaque burden and plaque composition in young adults.
Akin F; Celik O; Ayca B; Altun I; Diker VO; Bıyık I; Siriopol D; Covic A; Kanbay M
J Investig Med; 2015 Apr; 63(4):613-9. PubMed ID: 25679296
[TBL] [Abstract][Full Text] [Related]
16. Serum vitamin D levels are independently associated with severity of coronary artery disease.
Akin F; Ayça B; Köse N; Duran M; Sari M; Uysal OK; Karakukcu C; Arinc H; Covic A; Goldsmith D; Okçün B; Kanbay M
J Investig Med; 2012 Aug; 60(6):869-73. PubMed ID: 22534630
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease.
Manghat P; Fraser WD; Wierzbicki AS; Fogelman I; Goldsmith DJ; Hampson G
Osteoporos Int; 2010 Nov; 21(11):1853-61. PubMed ID: 20012018
[TBL] [Abstract][Full Text] [Related]
18. Association of serum FGF-23, klotho, fetuin-A, osteopontin, osteoprotegerin and hs-CRP levels with coronary artery disease.
Göçer K; Aykan AÇ; Kılınç M; Göçer NS
Scand J Clin Lab Invest; 2020 Jul; 80(4):277-281. PubMed ID: 32077762
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor-23 and calcium phosphate product in young chronic kidney disease patients: a cross-sectional study.
Yasin A; Liu D; Chau L; Madrenas J; Filler G
BMC Nephrol; 2013 Feb; 14():39. PubMed ID: 23413976
[TBL] [Abstract][Full Text] [Related]
20. Disordered mineral metabolism and vascular calcification in nondialyzed chronic kidney disease patients.
Mehrotra R
J Ren Nutr; 2006 Apr; 16(2):100-18. PubMed ID: 16567266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
